Curriculum
Evidence-Based Pharmacology Review for 2024: Opioids, Sinusitis, Asthma, COPD, Hypertension and Hyperlipidemia
Stay current with the latest pharmacology guidelines across therapeutic areas with this free curriculum
CME Information
3.25 AMA PRA Category 1 Credits, 3.25 ABIM MOC or 3.69 AANP, 3.69 AANP Pharm
Release Date: 12/19/2023
Available for credit until 12/18/2024
Topics
Learning Objectives
- Outline guideline recommendations for prescribing opioids and available tools for safe opioid prescribing
- Review the diagnosis of opioid use disorder (OUD) and understand the indications and prescribing information for buprenorphine in OUD
- Review risks of opioid use during pregnancy
- Outline recommended guidelines for tapering opioids
- Discuss how to approach the use of cannabis by patients also using opioids long term
- Interpret results of a urine drug test as part of pain management contract
- Differentiate between the symptoms of acute rhinosinusitis versus acute bacterial rhinosinusitis/acute bacterial sinusitis.
- Construct an appropriate treatment plan for acute bacterial rhinosinusitis in the adult population and acute bacterial sinusitis in the pediatric population
- Review the definitions and clinical presentation of asthma and COPD and outline guideline-recommended treatments
- Review recommended treatments for dyslipidemia, describe the components of the lipid panel, and discuss management of musculoskeletal side effects for patients taking statins
- Outline recommended practice guidelines and review available pharmacological options for managing hypertension in the outpatient clinical setting
Courses
3.25 CME/CE CREDITS
6 Courses
-
Podcast
-
Podcast
-
Podcast
-
Podcast
-
Podcast
-
Podcast
About the Curator
Assistant Professor and Coordinator AGPCNP Track
University of Massachusetts Chan Medical School
Tan Chingfen Graduate School of Nursing
Worcester, MA